Clinical Trial Update: Safety and Efficacy of the Full Face Applications of Variable Doses of a Commercial Botulinum Toxin Type a (Dysport®) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of full-face applications of variable doses of Dysport (botulinum toxin type A) for sun-induced wrinkles, completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sun-induced Wrinkles

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Hexsel Dermatology Clinic | Conditions: Sun-induced Wrinkles | Phase 4 | Status: COMPLETED | Results posted: 2020-09-17